The National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), selected four academic institutions to award $23 million to establish centers of excellence to research delivery of cancer-related care through telehealth. The... Read More
Articles | Community Oncology Practices & Other Dispensing Physician Practices | Dispensing Physician Practices and Dispensing Physicians | Medical Practice Representation | Physician Dispensing | Physician Dispensing | Telehealth and Telemedicine | Telehealth and Telemedicine | Value Based Care | Value Based Care

As previously reported, Frier Levitt filed suit against the New York Department of Health and the New York State Department of Education on behalf of an independent New York oncology practice in an effort to void the State’s new and legally... Read More
Articles | Community Oncology Practices & Other Dispensing Physician Practices | Healthcare | Healthcare Law | Life Sciences | Pharmacy Law

On June 29, 2022, the Department of Justice (“DOJ”) announced the formation of the New England Prescription Opioid (NEPO) Strike Force. This strike force will investigate and vigorously prosecute healthcare providers involved in healthcare fraud... Read More
All types of single and multi-specialty medical practice groups | Articles | Chain Pharmacies | Community Oncology Practices & Other Dispensing Physician Practices | Community, Retail Pharmacies | Digital Pharmacies | Dispensing Physician Practices and Dispensing Physicians | Federal and State Fraud and Abuse Counseling | Federal and State Fraud and Abuse Counseling | Fertility Pharmacies | Healthcare Practice Compliance | Hospitals and Healthcare Systems | Long-Term Care Pharmacies | Medical Practice Representation | Pain Management Compliance | Physician Dispensing | Physician Dispensing | Physicians and Medical Practices of all Specialties | Professional Practice Representation | Provider Relationship | Regulatory Compliance, including FDA, DEA and HIPAA | Specialty Pharmacies | Supermarket Pharmacies | Traditional Compounding Pharmacies (503A) | Urologist | White Collar Criminal Defense & Government Investigations | White Collar Defense and Government Investigation

On May 9, 2022, the Centers for Medicare and Medicaid Services (CMS) released a Final Rule (Final Rule) entitled, “Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs.” ... Read More
All types of single and multi-specialty medical practice groups | Articles | Community Oncology Practices & Other Dispensing Physician Practices | Community, Retail Pharmacies | Digital Pharmacies | DIR Fees | Dispensing Physician Practices and Dispensing Physicians | Healthcare | Healthcare Law | Healthcare Practice Compliance | Life Sciences | Medicare and Insurance Audits | Medicare Audit Appeals | Medicare, Medicaid, and Other Commercial Payor Audits & Appeals | Pharmaceutical Wholesalers | Physician Dispensing | Physician Dispensing | Physicians and Medical Practices of all Specialties | Specialty Pharmacies | Supermarket Pharmacies | Traditional Compounding Pharmacies (503A)

Earlier this month, the federal government intervened in a qui tam action originally filed in 2017 against a Tennessee hospital system, Methodist Le Bonheur Healthcare and Methodist Healthcare-Memphis Hospitals (collectively, “Methodist”),... Read More
340B Covered Entity and Contract Pharmacy Regulatory and Contract Support | Antitrust Tools Available to Combat PBM Abuse of Pharmacies | Articles | Buying and Selling Medical Practices including Private Equity Transactions | Community Oncology Practices & Other Dispensing Physician Practices | Healthcare | Hospitals and Healthcare Systems | PBM Qui Tam Lawsuits

On November 17, 2021, members of the Congressional Oversight Committee held a public hearing, called, “Reviewing the Role of Pharmacy Benefit Managers in Pharmaceutical Markets.”  The panelists on the forum included pharmacy and community... Read More
Articles | Community Oncology Practices & Other Dispensing Physician Practices | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law

As earlier noted, the New York State Department of Health (“NYDOH”) and the New York State Department of Education (“NYSED”) promulgated a so-called “policy,” which is actually a poorly-disguised agency rule, precluding New York... Read More
Articles | Community Oncology Practices & Other Dispensing Physician Practices | Life Sciences | Pharmacy Law | Physician Dispensing

In an apparent unlawful exercise of authority, the New York Department of Health (“NYDOH”) and the New York State Education Department (“NYSED”) quietly slipped a de facto agency rule into the NYDOH’s Medicaid Pharmacy Manual Policy... Read More
Articles | Community Oncology Practices & Other Dispensing Physician Practices | Life Sciences | Pharmacy Law | Physician Dispensing

The dietary supplement market has continued to be one that has captivated consumers and healthcare professionals alike.  While consumers can purchase certain dietary supplements and vitamins at a variety of retailers, an increasing number of... Read More
Articles | Community Oncology Practices & Other Dispensing Physician Practices | Community, Retail Pharmacies | Life Sciences | Pharmacy Law | Physician Dispensing | White Collar Criminal Defense & Government Investigations

On October 26, 2020, the Food and Drug Administration (FDA) issued its long awaited final MOU which describes the conditions under which certain compounded drugs by a pharmacist in a state-licensed pharmacy, or by a licensed physician, are exempt... Read More
Community Oncology Practices & Other Dispensing Physician Practices | Integrated Delivery Network and Hospital System Pharmacy | Life Sciences | State and National Pharmacy Associations | Traditional Compounding Pharmacies (503A)